Nitric oxide | Dexamethasone | ||||||
---|---|---|---|---|---|---|---|
Treatment | Controls | Treatment | Controls | ||||
CLD risk score3-150 | 0.77 (0.43-1.0) | 0.79 (0.27-0.98) | 0.75 (0.43-1.0) | 0.80 (0.27-1.0) | |||
MAP3-150 | 9 (4-21) | 7 (3-12) | 8 (3-21) | 8 (4-18) | |||
Maximum PIP3-150 | 28 (16-42) | 24 (16-38) | 28 (16-42) | 26 (16-40) | |||
FIO2 3-150 | 0.45 (0.22-1.0) | 0.37 (0.21-0.72) | 0.4 (0.21-1.0) | 0.36 (0.21-0.84) | |||
Oxygenation index3-150 | 7.9 (1.6-46.7) | 3.9 (1.2-11.5) | 7.9 (1.2-46.7) | 4.1 (1.4-28) | |||
PDA | 5 (25%) | 4 (19%) | 3 (14%) | 5 (24%) | |||
Pneumothorax | 5 (25%) | 3 (14%) | 5 (24%) | 3 (14%) | |||
IVH grade | |||||||
1 | 3 (15%) | 1 (5%) | 2 (10%) | 2 (10%) | |||
2 | 9 (45%) | 10 (45%) | 12 (57%) | 7 (33%) | |||
Trial entry (hours)3-150 | 99 (96-113) | 104 (96-120) | 104 (96-120) | 98 (96-114) |
↵3-150 Values expressed as median (range).
MAP = mean airway pressure; FIO2 = fractional inspired oxygen concentration; PIP = maximum peak inspiratory pressure.